{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T06:32:01Z","timestamp":1696314721386},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK-088136"],"award-info":[{"award-number":["DK-088136"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UL1 RR025744"],"award-info":[{"award-number":["UL1 RR025744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jacl.2015.06.009","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T12:56:16Z","timestamp":1434632176000},"page":"658-663","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals"],"prefix":"10.1016","volume":"9","author":[{"given":"Danit","family":"Ariel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahim","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy A.","family":"Lamendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylene","family":"Grove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Tomasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald M.","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacl.2015.06.009_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jacl.2015.06.009_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00592-011-0329-2","article-title":"Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes","volume":"50","author":"Faghihimani","year":"2013","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.jacl.2015.06.009_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-159-1-201307020-00003","article-title":"Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial","volume":"159","author":"Goldfine","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jacl.2015.06.009_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-012-2819-3","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","volume":"56","author":"Goldfine","year":"2013","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.jacl.2015.06.009_bib5","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2337\/dc13-2977","article-title":"Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study","volume":"37","author":"Kim","year":"2014","journal-title":"Diabetes care"},{"issue":"6","key":"10.1016\/j.jacl.2015.06.009_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.jacl.2015.06.009_bib7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jacc.2013.01.079","article-title":"Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications","volume":"62","author":"Martin","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jacl.2015.06.009_bib8","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"6 Suppl","key":"10.1016\/j.jacl.2015.06.009_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2014.10.002","article-title":"National Lipid Association Annual Summary of Clinical Lipidology 2015","volume":"8","author":"Bays","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2015.06.009_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacl.2011.07.005","article-title":"Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists","volume":"5","author":"Davidson","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2015.06.009_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2015.06.009_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cll.2006.07.004","article-title":"Cholesterol profile measurement by vertical auto profile method","volume":"26","author":"Kulkarni","year":"2006","journal-title":"Clin Lab Med"},{"issue":"6 Pt 1","key":"10.1016\/j.jacl.2015.06.009_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1373\/49.6.1014","article-title":"Multiple lipoprotein abnormalities associated with insulin resistance in healthy volunteers are identified by the vertical auto profile-II methodology","volume":"49","author":"Chu","year":"2003","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.jacl.2015.06.009_bib14","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1172\/JCI106433","article-title":"Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes","volume":"49","author":"Shen","year":"1970","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jacl.2015.06.009_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2337\/diab.30.5.387","article-title":"Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp","volume":"30","author":"Greenfield","year":"1981","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.jacl.2015.06.009_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/BF00404344","article-title":"Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test","volume":"37","author":"Pei","year":"1994","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jacl.2015.06.009_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.metabol.2012.10.002","article-title":"Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp","volume":"62","author":"Knowles","year":"2013","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.jacl.2015.06.009_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1996.03540110036029","article-title":"A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction","volume":"276","author":"Stampfer","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacl.2015.06.009_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.95.1.69","article-title":"Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study","volume":"95","author":"Lamarche","year":"1997","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jacl.2015.06.009_bib20","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jacl.2015.06.009_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.atherosclerosis.2014.01.034","article-title":"Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease","volume":"233","author":"Williams","year":"2014","journal-title":"Atherosclerosis"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415002652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415002652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T19:02:08Z","timestamp":1599159728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287415002652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1933287415002652"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.06.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}